维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Mesters RM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Stable remission afte radministration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refratory acute myeloid leukemia显示文摘	Mesters RM Padro T Bieker R	2001	Blood2001，98，1：	1
2	Lymphangiogenesis in cancer:current perspectives显示文摘	LIERSCH R BIERMANN C MESTERS RM	2010	Recent Results Cancer Res2010，180，1：	1
3	Lymphangiogenesis in cancer:current perspectives显示文摘	Liersch R Biermann C Mesters RM		Recent Results in Cancer Research0，，：	1
4	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications显示文摘	Mesters RM Helterbrand J Utterback BG	2000	Crit Care Med2000，28，7：	1
5	The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells显示文摘	Padro T Mesters RM Dankbar B	2002	J Cell Sci2002，115，9：	1
6	Oral anticoagulation versus low-molecular heparin (LMWH)显示文摘	Mesters RM	2000	Internist (Berl)2000，41，8：	1
7	Satble remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refratory acute myeloid leukemia显示文摘	Mesters RM Padró T Bicker R	2001	Blood2001，98，1：	1
8	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications显示文摘	Mesters RM Helterbrand J Utterback BG	2000	Crit Care Med2000，28，：	1
9	Reciprocalchanges in circulating interleukin-6and its soluble receptorduring evolving sepsis in leukocycopenic patients显示文摘	Ostermann H Kratz-Alliers K Mesters RM	1997	Infect Dis1997，176，3：	1
10	Factor VlIa and antithrombin Ⅲ activity during severe sepsis and sepic shock in neutropoenic patients 显示文摘	Mesters RM Mannucci PM Coppola R	1996	Blood1996，88，3：	1
11	Satble remission after ad- ministration of thereceptor tyrosine kinase inhibitor SU5416 in a pa- tient with refratory acute myeloid leukemia 显示文摘	Mesters RM Padro T Bicker R	2001	Blood2001，98，1：	1
12	Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia 显示文摘	Ruiz S Bieker R Burger H Steins M Kienast J Buchner T Berdel WE Mesters RM	2000	Blood2000，95，8：	1
13	Factor Ⅶa and antithrombin Ⅲ activity during severe sepsis and septic shock in neutropenic patients显示文摘	Mesters RM Mannucci PM Coppola R	1996	Blood1996，88，3：	1
14	Factor Ⅶa and antithrombin Ⅲ activity during severe sepsis and septic shock in neutropenic patients 显示文摘	Mesters RM Mannucci PM Coppola R	1996	Blood1996，88，：	1
15	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications 显示文摘	Mesters RM Heherbrand J Utterback BG	2000	Crit Care Med2000，28，7：	1
16	Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia 显示文摘	Mesters RM Padro T Bieker R	2001	Blood2001，98，：	1
17	Angiogenesis in patients with hematologic malignancies 显示文摘	Mesters RM Padro T Steins M	2001	Oncologie2001，24，5：	1
18	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications 显示文摘	Mesters RM Heherbrand J Utterback BG	2000	Crit Care Med2000，28，7：	1
19	In situ and infiltrating ductal carcinoma arising in a breast hamartoma显示文摘	Mester J Simmons RM Vazquez MF	2000	Am J Roentgenol2000，175，1：	1
20	Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refratory acute myeloid leukemia 显示文摘	Mesters RM Padro T Bieker R	2001	Blood2001，98，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示